The Parkinson's-associated protein DJ-1 regulates the 20S proteasome

Nature Communications

Volumn 6, Issue , 2015, Pages

  Moscovitz, Oren ^a   Ben Nissan, Gili ^a   Fainer, Irit ^a   Pollack, Dan ^a   Mizrachi, Limor ^a   Sharon, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; NQO1 PROTEIN; PROTEASOME; PROTEIN P53; REGULATOR PROTEIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ATP DEPENDENT 26S PROTEASE; DJ-1 PROTEIN, MOUSE; NQO1 PROTEIN, HUMAN; NQO1 PROTEIN, MOUSE; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; PEROXIREDOXIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SIGNAL PEPTIDE;

CYTOLOGY; DEGRADATION; ENZYME ACTIVITY; INHIBITION; PROTEIN; SIGNAL; SUBSTRATE;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; UPREGULATION; ANIMAL; CELL LINE; ELECTROSPRAY MASS SPECTROMETRY; GENETICS; HEK293 CELL LINE; HELA CELL LINE; IMMUNOPRECIPITATION; METABOLISM; MUTATION; RAT; TANDEM MASS SPECTROMETRY;

ANIMALS; CELL LINE; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUTATION; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; ONCOGENE PROTEINS; OXIDATIVE STRESS; PEROXIREDOXINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84926328165     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7609     Document Type: Article

References (70)

1. Cookson, M. R. DJ-1 PINK1, and their effects on mitochondrial pathways. Mov. Disord 25 (Suppl 1), S44-S48 (2010).
2. Wilson, M. A. The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid. Redox. Signal. 15, 111-122 (2011).
3. Lucas, J. I. & Marin, I. A new evolutionary paradigm for the Parkinson disease gene DJ-1. Mol. Biol. Evol. 24, 551-561 (2007).
4. Annesi, G. et al. DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Ann. Neurol. 58, 803-807 (2005).
5. Lev, N., Ickowicz, D., Barhum, Y., Melamed, E. & Offen, D. DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS. J. Mol. Neurosci. 38, 94-102 (2009).
6. Cookson, M. R. Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring Harb. Perspect. Med. 2, a009415 (2012).
7. Canet-Aviles, R. M. et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad. Sci. USA 101, 9103-9108 (2004).
8. Taira, T. et al. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5, 213-218 (2004).
9. Junn, E., Jang, W. H., Zhao, X., Jeong, B. S. & Mouradian, M. M. Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J. Neurosci. Res. 87, 123-129 (2009).
10. Chen, J., Li, L. & Chin, L. S. Parkinson disease protein DJ-1 converts from a zymogen to a protease by carboxyl-terminal cleavage. Hum. Mol. Genet. 19, 2395-2408 (2010).
11. Shendelman, S., Jonason, A., Martinat, C., Leete, T. & Abeliovich, A. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol. 2, e362 (2004).
12. Taira, T., Iguchi-Ariga, S. M. & Ariga, H. Co-localization with DJ-1 is essential for the androgen receptor to exert its transcription activity that has been impaired by androgen antagonists. Biol. Pharm. Bull. 27, 574-577 (2004).
13. Junn, E. et al. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc. Natl Acad. Sci. USA 102, 9691-9696 (2005).
14. Kim, R. H. et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7, 263-273 (2005).
15. Hod, Y., Pentyala, S. N., Whyard, T. C. & El-Maghrabi, M. R. Identification and characterization of a novel protein that regulates RNA-protein interaction. J. Cell. Biochem. 72, 435-444 (1999).
16. Zhou, W. & Freed, C. R. DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J. Biol. Chem. 280, 43150-43158 (2005).
17. Goldberg, M. S. et al. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45, 489-496 (2005).
18. Fan, J. et al. DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J. Biol. Chem. 283, 4022-4030 (2008).
19. Shinbo, Y., Taira, T., Niki, T., Iguchi-Ariga, S. M. & Ariga, H. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int. J. Oncol. 26, 641-648 (2005).
20. Ben-Nissan, G. & Sharon, M. Regulating the 20S Proteasome ubiquitin-independent degradation pathway. Biomolecules 4, 862-884 (2014).
21. Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (1998).
22. Aiken, C. T., Kaake, R. M., Wang, X. & Huang, L. Oxidative stress-mediated regulation of proteasome complexes. Mol. Cell. Proteomics 10, R.110.006924 (2011).
23. Grune, T., Reinheckel, T., Joshi, M. & Davies, K. J. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J. Biol. Chem. 270, 2344-2351 (1995).
24. Shringarpure, R., Grune, T., Mehlhase, J. & Davies, K. J. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J. Biol. Chem. 278, 311-318 (2003).
25. Pickering, A. M., Linder, R. A., Zhang, H., Forman, H. J. & Davies, K. J. Nrf2-dependent induction of proteasome and Pa28alphabeta regulator are required for adaptation to oxidative stress. J. Biol. Chem. 287, 10021-10031 (2012).
26. Breusing, N. & Grune, T. Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol. Chem. 389, 203-209 (2008).
27. Davies, K. J. Degradation of oxidized proteins by the 20S proteasome. Biochimie 83, 301-310 (2001).
28. Grune, T., Reinheckel, T. & Davies, K. J. Degradation of oxidized proteins in mammalian cells. FASEB J 11, 526-534 (1997).
29. Shringarpure, R., Grune, T. & Davies, K. J. Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells. Cell. Mol. Life Sci. 58, 1442-1450 (2001).
30. Wilson, M. A., Collins, J. L., Hod, Y., Ringe, D. & Petsko, G. A. The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc. Natl Acad. Sci. USA 100, 9256-9261 (2003).
31. Asher, G., Dym, O., Tsvetkov, P., Adler, J. & Shaul, Y. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry 45, 6372-6378 (2006).
32. Dinkova-Kostova, A. T. & Talalay, P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch. Biochem. Biophys. 501, 116-123 (2010).
33. Ross, D. & Siegel, D. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol. 382, 115-144 (2004).
34. Bian, J. T., Zhao, H. L., Zhang, Z. X., Bi, X. H. & Zhang, J. W. Association of NAD(P)H:quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese. J. Mol. Neurosci. 34, 235-240 (2008).
35. Tsvetkov, P., Adamovich, Y., Elliott, E. & Shaul, Y. E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients. J. Biol. Chem. 286, 8839-8845 (2011).
36. Moscovitz, O. et al. A mutually inhibitory feedback loop between the 20S proteasome and its regulator. Mol. Cell 47, 76-86 (2012).
37. Asher, G., Tsvetkov, P., Kahana, C. & Shaul, Y. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 19, 316-321 (2005).
38. Ferrington, D. A. et al. Selective degradation of oxidized calmodulin by the 20S proteasome. J. Biol. Chem. 276, 937-943 (2001).
39. Thrower, J. S., Hoffman, L., Rechsteiner, M. & Pickart, C. M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102 (2000).
40. Henderson, A., Erales, J., Hoyt, M. A. & Coffino, P. Dependence of proteasome processing rate on substrate unfolding. J. Biol. Chem. 286, 17495-17502 (2011).
41. Jerabek-Willemsen, M., Wienken, C. J., Braun, D., Baaske, P. & Duhr, S. Molecular interaction studies using microscale thermophoresis. Assay Drug Dev. Technol. 9, 342-353 (2011).
42. Zhou, W., Zhu, M., Wilson, M. A., Petsko, G. A. & Fink, A. L. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J. Mol. Biol. 356, 1036-1048 (2006).
43. Park, S. et al. Reconfiguration of the proteasome during chaperone-mediated assembly. Nature 497, 512-516 (2013).
44. Hall, Z., Hernandez, H., Marsh, J. A., Teichmann, S. A. & Robinson, C. V. The role of salt bridges, charge density, and subunit flexibility in determining disassembly routes of protein complexes. Structure 21, 1325-1337 (2013).
45. Salvat, C. et al. Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Requirements on different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo. Eur. J. Biochem. 267, 3712-3722 (2000).
46. Zhang, Q. et al. DJ-1 promotes the proteasomal degradation of Fis1: implications of DJ-1 in neuronal protection. Biochem. J. 447, 261-269 (2012).
47. Blackinton, J. et al. Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization. Brain Res. Mol. Brain Res. 134, 76-83 (2005).
48. Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H. & Weissman, A. M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945-8951 (2000).
49. Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W. & Ting, J. P. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl Acad. Sci. USA 103, 15091-15096 (2006).
50. Malhotra, D. et al. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am. J. Respir. Crit. Care Med. 178, 592-604 (2008).
51. Venugopal, R. & Jaiswal, A. K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl Acad. Sci. USA 93, 14960-14965 (1996).
52. Reinheckel, T. et al. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem. J. 335 (Pt 3), 637-642 (1998).
53. Reinheckel, T., Ullrich, O., Sitte, N. & Grune, T. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch. Biochem. Biophys. 377, 65-68 (2000).
54. Kalo, E. et al. Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species. J. Cell Sci. 125, 5578-5586 (2012).
55. Pickering, A. M. & Davies, K. J. Differential roles of proteasome and immunoproteasome regulators Pa28alphabeta, Pa28gamma and Pa200 in the degradation of oxidized proteins. Arch. Biochem. Biophys. 523, 181-190 (2012).
56. Ustrell, V., Hoffman, L., Pratt, G. & Rechsteiner, M. PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 21, 3516-3525 (2002).
57. Ruschak, A. M. & Kay, L. E. Proteasome allostery as a population shift between interchanging conformers. Proc. Natl Acad. Sci. USA 109, E3454-E3462 (2012).
58. Shi, L. & Kay, L. E. Tracing an allosteric pathway regulating the activity of the HslV protease. Proc. Natl Acad. Sci. USA 111, 2140-2145 (2014).
59. Itoh, K. et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322 (1997).
60. Nguyen, T., Huang, H. C. & Pickett, C. B. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J. Biol. Chem. 275, 15466-15473 (2000).
61. Dhakshinamoorthy, S. & Jaiswal, A. K. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 20, 3906-3917 (2001).
62. Grune, T. et al. HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic. Biol. Med. 51, 1355-1364 (2011).
63. Wang, X., Yen, J., Kaiser, P. & Huang, L. Regulation of the 26S proteasome complex during oxidative stress. Sci. Signal. 3, ra88 (2010).
64. Taguchi, K., Motohashi, H. & Yamamoto, M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16, 123-140 (2011).
65. Lee, S. et al. Involvement of the Nrf2-proteasome pathway in the endoplasmic reticulum stress response in pancreatic beta-cells. Toxicol. Appl. Pharmacol. 264, 431-438 (2012).
66. Jung, T. & Grune, T. The proteasome and its role in the degradation of oxidized proteins. IUBMB Life 60, 743-752 (2008).
67. Shang, F. & Taylor, A. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem. J. 307 (Pt 1), 297-303 (1995).
68. Dyson, H. J. & Wright, P. E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6, 197-208 (2005).
69. Gabizon, R. et al. Specific recognition of p53 tetramers by peptides derived from p53 interacting proteins. PLoS ONE 7, e38060 (2012).
70. Gan, L., Johnson, D. A. & Johnson, J. A. Keap1-Nrf2 activation in the presence and absence of DJ-1. Eur. J. Neurosci. 31, 967-977 (2010).